title: Draft guideline on detection of toxicity to reproduction for medicinal products.
authors.affiliation: Institute for Drugs, Federal Health Administration (BGA), Germany.
authors.forename: R
authors.initials: R
authors.lastname: Bass
authors.forename: B
authors.initials: B
authors.lastname: Ulbrich
authors.forename: A G
authors.initials: AG
authors.lastname: Hildebrandt
authors.forename: J
authors.initials: J
authors.lastname: Weissinger
authors.forename: O
authors.initials: O
authors.lastname: Doi
authors.forename: C
authors.initials: C
authors.lastname: Baeder
authors.forename: S
authors.initials: S
authors.lastname: Fumero
authors.forename: Y
authors.initials: Y
authors.lastname: Harada
authors.forename: H
authors.initials: H
authors.lastname: Lehmann
authors.forename: J
authors.initials: J
authors.lastname: Manson
mesh_terms: D000014:Abnormalities, Drug-Induced; D000818:Animals; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D012098:Reproduction / Q000187:drug effects*; D014116:Toxicology / Q000592:standards*